Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Morphic Therapeutic (MORF)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 12
  • 1 comments

(28% Negative) MORPHIC HOLDING, INC. (MORF) Reports 957% Loss Increase for 2022-06-30

Comment Full text

Seres Therapeutics Inc (MCRB)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 9
  • 1 comments

(75% Positive) Seres Therapeutics, Inc. (MCRB) Reports 31% Loss Reduction for 2022-06-30

Comment Full text

Pacira BioSciences Inc (PCRX)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 14
  • 1 comments

(51% Neutral) PACIRA BIOSCIENCES, INC. (PCRX) Reports Profit for 2022-06-30

Comment Full text

Lexicon Pharmaceuticals Inc. (LXRX)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 14
  • 1 comments

(75% Positive) Lexicon Pharmaceuticals, Inc. (LXRX) Reports Net Loss for 2022-06-30

Comment Full text

Kura Oncology Inc (KURA)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 14
  • 1 comments

(51% Neutral) KURA ONCOLOGY, INC. (KURA) Reports Net Loss for 2022-06-30

Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 8
  • 1 comments

(71% Positive) REGENERON PHARMACEUTICALS, INC. (REGN) Reports 131% Profit Growth for 2022-06-30

Comment Full text

Horizon Therapeutics plc (was acquisited by Amgen (NASDAQ: AMGN)) (HZNP)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 10
  • 1 comments

(19% Negative) HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY (HZNP) Reports 87% Profit Decline for 2022-06-30

Comment Full text

Surface Oncology Inc (was by Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) on 16/06/2023) (SURF)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 17
  • 1 comments

(28% Negative) SURFACE ONCOLOGY, INC. (SURF) Reports 82% Loss Increase for 2022-06-30

Comment Full text

United Therapeutics Corporation (UTHR)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 17
  • 1 comments

(47% Neutral) United Therapeutics Corporation (UTHR) Reports 44% Profit Decline for 2022-06-30

Comment Full text

Summit Plc (SMMT)

  • Event
  • Aug. 02, 2022, 21:09 UTC
  • 14
  • 1 comments

(10% Negative) Summit Therapeutics Inc. (SMMT) Announces Clinical Trial Timeline Adjustment

Comment Full text
  • Previous
  • 141
  • 142
  • 143
  • 144
  • 145
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2261)
  • SEC News(189350)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124575)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin